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Abstract
The aim of this study was to assess the effects of 2 weeks of supplementation with ( )-hydroxycitrate (HCA) and HCA combined with
medium-chain triglycerides (MCT) on satiety and energy intake. The experimental design consisted of three intervention periods of 2 weeks
separated by washout periods of 2 or 6 weeks in a double-blind, placebo-controlled, randomized, and crossover design. Seven male and 14
female normal to moderately obese subjects (mean ± S.D.; age, 43 ± 10 years; body mass index, 27.6 ± 2.0 kg/m2) participated in this study.
Subjects consumed three self-selected meals and four isoenergetic snacks daily with either no supplementation (PLA), with 500 mg HCA
(HCA), or 500 mg HCA and 3 g MCT (HCA+MCT). Each intervention period ended with a test day, consisting of a standardized breakfast
and ad libitum a lunch and a dinner. There was a significant body weight (BW) loss during the 2 weeks of intervention (PLA,  0.5 ± 0.3 kg,
P< .05; HCA,  0.4 ± 0.2 kg, P < .05; HCA+MCT,  0.7 ± 0.2 kg, P< .01), but this reduction was not different between treatments.
Twenty-four-hour energy intake (PLA, 8.1 ± 0.3 MJ; HCA, 8.3 ± 0.3 MJ; HCA+MCT, 8.4 ± 0.3 MJ) and the area under the curve of the
appetite-related parameters during the test day were similar for all treatments. Two weeks of supplementation with HCA and HCA combined
with MCT did not result in increased satiety or decreased energy intake compared to placebo in subjects losing BW. D 2001 Elsevier Science
Inc. All rights reserved.
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1. Introduction
The increasing incidence of obesity is a recognized
medical problem in developed countries [1]. However,
treatment of obesity is often unsuccessful. Weight loss can
be achieved, but long-term weight maintenance after weight
loss is rarely shown [2–4]. Therefore, identification of
substances that increase satiety or at least sustain satiety
during energy restriction is needed. One possible way to
improve satiety is to increase hepatic fatty acid oxidation
[5]. Therefore, finding ways to stimulate hepatic fatty acid
oxidation should be promising for appetite and weight
control. In this experiment, we propose to interfere in
postingestive modulation of fat-induced satiety by stimulat-
ing hepatic fatty acid oxidation. We therefore investigated
the potential of ( )-hydroxycitrate (HCA), which is
believed to induce hepatic fatty acid oxidation [6–8], and
medium-chain triglycerides (MCT), which are more readily
oxidized [9–12], to increase satiety.
HCA is an active ingredient that is extracted from the
rind of the fruit Garcinia cambogia, a native species to
India, and is promoted as a weight loss agent. HCA is an
inhibitor of ATP-citrate-lyase, a cytosolic (extramitochon-
drial) enzyme that catalyzes the cleavage of citrate to
oxaloacetate and acetyl-CoA [6,13,14]. The effect of
HCA would therefore be to reduce the acetyl-CoA pool,
limiting the availability of 2-carbon groups required for the
synthesis of fats and cholesterol. In this respect, HCA might
promote weight maintenance by inhibiting or limiting the
capacity for de novo lipogenesis [13]. Furthermore, HCA
might induce weight loss through increased satiety by
increasing fatty acid oxidation [15,16], probably by inhibi-
tion of acetyl-CoA and subsequently of malonyl-CoA
formation that, in turn, would stimulate carnitine transferase
activity, or by increasing the rate of glycogen synthesis in
the liver [17]. Up to now, however, the results on the effects
of HCA on appetite, body weight (BW), and energy
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expenditure, and its possible contribution as a weight loss
agent in humans, are controversial [18–21]. Several studies
found a positive effect of HCA administration alone or in
combination with other ingredients on appetite, energy
intake, BW loss, or energy expenditure [22–27], but others
did not [28–32].
MCT have been repeatedly suggested to contribute to the
control of BW. MCT are known to be rapidly hydrolyzed
and absorbed [33,34]. It has been shown that fatty acids
delivered by MCT are preferentially oxidized and poorly
stored within tissues, and that MCT have a marked thermic
effect [35]. In addition to that, MCT have been shown to
have satiating properties and to decrease food intake
[11,12,36] by involving a cascade of preabsorptive and
postabsorptive mechanisms. However, the exact mechanism
underlying the reduction in food intake after MCT ingestion
is not fully understood [33,37].
In a previous study, we concentrated on the effects of
HCA and HCA combined with MCT on energy expenditure
while feeding subjects in energy balance [32]. In the present
study, we concentrated on the effects of HCA and HCA
combined with MCT on satiety and energy intake during ad
libitum feeding.
Therefore, the aim of the present study was to investigate
the effects of chronic ingestion of HCA and MCT on satiety
and energy intake. We hypothesized that HCA supplementa-
tion might affect BW regulation by inducing satiety and
reducing food intake. We further hypothesized that the
combination of HCA and MCT may have a stronger effect
on satiety compared to HCA alone.
2. Methods
2.1. Subjects
Seven male and 14 female normal to moderately obese
subjects participated in this study. The subjects were
recruited by advertisements in local newspapers, in which
we asked for moderately obese male and female subjects
who wanted to participate in a study on the effects of
natural food supplements on appetite, food intake, and
BW. Selection took place following health criteria (no
diabetes, no cardiovascular diseases, no medical treatment)
and BW criteria (body mass index: 24–32 kg/m2). Base-
line characteristics are presented in Table 1. The nature and
risks of the experimental procedure were explained to the
subjects, and all subjects gave their written informed
consent. The study was approved by the Ethics Committee
of Maastricht University.
2.2. Experimental design
The experiment had a double-blind, placebo-controlled,
randomized, crossover design. The experimental design
consisted of three intervention periods of 2 weeks sepa-
rated by washout periods of 2 or 6 weeks (Fig. 1) to ensure
that the women were always in the same phase of the
menstrual cycle. Statistical analysis (t-test) of the results
revealed that there were no differences between the wash-
out periods of 2 or 6 weeks, with respect to the energy
intake on the test day.
During the washout periods, the subjects consumed a
self-selected and self-prepared diet. During the intervention
periods, the subjects consumed at home three self-selected
and self-prepared meals daily (breakfast, lunch, and dinner)
with no restriction regarding type and amount of food. They
were instructed to drink maximally one glass of alcoholic
beverage per day. Between the meals, the subjects con-
sumed an isoenergetic snack (cereal bar) of 22 g (energy,
420 kJ; protein, 0.7 g; fat, 4 g; carbohydrate, 14 g; dietary
fibre, 0.5 g) with no supplementation (PLA), with supple-
mentation of 500 mg HCA (850 mg SuperCitrimax HCA
600 SXG, HCA content: 58.81%, EuroChem Feinchemie,
Mu¨nchen, Germany), or 500 mg HCA and 3 g MCT
(HCA+MCT). The dosage of HCA used was similar or
even higher to that used in several studies in which an effect
of HCA on BW loss was found (500 mg, 3 times/day
[22,23]; 55–110 mg, 2 times/day [24]). The snacks were
consumed at four fixed time points: 1 h before lunch, 2 h
after lunch, 1 h before dinner, and 2 h after dinner. The
snack was used for practical comfort, because HCA (pow-
der) and MCT (oil) could be easily incorporated into the
product. Between the meals, the subjects were not allowed
to eat with exception of the prescribed snacks. They were
allowed to drink ad libitum water, coffee, and tea (without
sugar and milk).
2.3. Anthropometry
BW was measured during screening, at the beginning,
after 1 week and at the end of each intervention period on a
digital balance accurate to 0.02 kg (Chyo-MW-150K, Japan)
with subjects in underwear, in the fasted state, and after
voiding their bladder. Height was measured to the nearest
0.1 cm during screening using a wall-mounted stadiometer
Table 1
Subjects characteristics at baseline
Mean ± S.D. Range
Age (years) 43 ± 10 29–57
Height (m) 170 ± 8 155–180
Weight (kg) 79.3 ± 9.0 61.2–93.0
Body mass index (kg/m2) 27.6 ± 2.0 24.0–31.5
Waist circumference (cm) 88 ± 8 74–104
Hip circumference (cm) 104 ± 6 95–116
WHR 0.85 ± 0.08 0.74–1.01
F1 (cognitive restraint) 8 ± 3 1–14
F2 (disinhibition) 6 ± 3 1–11
F3 (hunger) 5 ± 3 0–10
Herman and Polivy restraint 16 ± 5 6–30
n= 21 subjects (7 men and 14 women).
F1–F3: Factors 1–3 of the TFEQ.
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(Seca, model 220, Hamburg, Germany). The body mass
index was calculated by BW/height2 (kg/m2).
The distribution of fat was investigated during screening
by measuring the waist and hip circumferences and calcula-
tion of the waist–hip ratio (WHR). The waist circumference
was measured at the site of the smallest circumference
between the rib cage and the ileac crest, with the subjects
in standing position. The hip circumference was measured at
the site of the largest circumference between the waist and
the thighs. The WHR was calculated by dividing the waist
circumference by the hip circumference.
2.4. Eating behavior
Eating behavior was analyzed during screening, at the
beginning, and at the end of each intervention period
using a validated Dutch translation of the Three-Factor
Eating Behavior Questionnaire (TFEQ) [38,39]. Cognitive
restrained and unrestrained eating behavior (Factor 1),
emotional eating and disinhibition (Factor 2), and the
subjective feeling of hunger (Factor 3) were scored. BW
concern and chronic dieting behavior were investigated
with the Herman and Polivy questionnaire (HP) [40]
during screening, at the beginning, and at the end of each
intervention period.
2.5. Daily energy intake
Energy intake over the previous week was recorded at
the beginning and at the end of each intervention period
using a food frequency questionnaire. Personal instruction
was given in advance. The questionnaires were analyzed
using the Dutch food composition table [41] and the
accessory computer program (Becel Nutrition Program
1988). Daily energy intake before and during intervention
was compared with predicted 24-h energy expenditure [42]
that amounted, on the average, to 10.6 ± 0.3 MJ/day in all
treatments. Since this was significantly higher compared to
the reported energy intakes (before intervention: PLA,
7.4 ± 0.5 MJ/day; HCA, 6.9 ± 0.5 MJ/day; HCA +MCT,
7.3 ± 0.6 MJ/day; during the second week of intervention:
PLA, 8.0 ± 0.5 MJ/day; HCA, 7.7 ± 0.4 MJ/day;
HCA+MCT, 7.8 ± 0.4 MJ/day), these data were not further
used to express daily energy intake.
2.6. Mood
Mood questionnaires were completed at the beginning
and at the end of each intervention period [43]. The subjects
indicated on anchored 100-mm visual analogue scales
ranging from ‘‘not at all’’ to ‘‘extremely’’ how relaxed,
gloomy, fine, angry, scared, and sad they felt.
2.7. Tolerance
Tolerance questionnaires were completed at the end of
each intervention period. The subjects indicated on a five-
point scale questionnaire (0 = not at all, 1 = less, 2 = some-
times, 3 = relatively much, 4 = very much) how intensively
they experienced unwell feeling, headache, weakness,
tiredness, nausea, vomit, eructation, abdominal pain, bloat-
ing, flatulence, constipation, diarrhea, dryness in the
mouth, changes in taste, increased sweat production, and
increased thirst.
2.8. Test day
At the end of each intervention period, the subjects were
invited for an experiment in the laboratory assessing 24-h
energy intake and appetite profile.
The subjects arrived between 07:30 and 09:00 h, always
at the same day of the week and at the same time of the
day. They received a standardized breakfast, consisting of
bread, butter, cheese, coffee, or tea. After breakfast, they
left and returned between 12:00 and 13:00 h for lunch.
Lunch, consisting of bread (brown, white), a choice of
sweet and savory bread filling (jam, chocolate vermicelli,
cheese, and ham), and different kinds of drinks (milk, tea,
and coffee), was consumed ad libitum. The subjects
returned again between 17:00 and 18:30 h for dinner.
Dinner, which consisted of a cooked meal (pasta or nasi
for vegetarians) and a dessert, was also consumed ad
libitum. The foods offered during the test day were typical
Dutch items, according to food consumption surveys [44].
Between the meals, the subjects were not allowed to eat
with exception of the prescribed snacks, water, coffee, and
tea (without sugar and milk). Energy intake and food
selection were determined.
Appetite profile during the day was scored on anchored
100-mm visual analogue scales and completed at 10 fixed
time points, respectively, immediately before and after
breakfast, in the morning between 10:00 and 11:00 h,
immediately before and after lunch, in the afternoon
between 14:30 and 15:30 h, immediately before and after
dinner, in the evening between 21:00 and 22:00 h, and
before sleeping [39].
Fig. 1. Experimental design. I.P. = intervention periods; W.O. =washout
periods;  = test day; "=measurement of body weight; HS = question-
naires on hunger and satiety; T = questionnaire on tolerance; FFQ= food
frequency questionnaire; TFEQ = questionnaires on eating behavior;
M= questionnaire on mood.
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2.9. Statistical analysis
Data are presented as means ± standard error (S.E.).
Differences between the treatments were determined by
analysis of variance (ANOVA) for repeated measures and
Sheffe’s F post hoc test (Statview SE Graphics). The
measurements at the beginning and at the end of the
experiment were compared using paired t-tests. Pearson
correlation coefficients, r, were calculated to determine the
relationship between selected variables. The level of sig-
nificance was set at P < .05.
3. Results
There was a significant BW loss during the 2 weeks of
treatment for the whole group (PLA,  0.5 ± 0.3 kg,
P < .05; HCA,  0.4 ± 0.2 kg, P < .05; HCA +MCT,
 0.7 ± 0.2 kg; P < .01). However, BW reduction was not
different between treatments for the whole group, as well as
for the men and women apart. BW loss was greater during
the first compared to the second and third intervention
periods ( 1.2 ± 0.5 kg vs.  0.2 ± 0.2 and  0.3 ± 0.2 kg,
respectively; P < .001).
Scores on the HP and the TFEQ questionnaires were
similar for all treatments and did not change during treatment.
There was no difference in mood before and after
intervention between treatments. The snacks were well
tolerated and values for complaints remained low. The
snacks were similarly tolerated in all treatments.
Twenty-four-hour energy intake during the test day for
the whole group was similar in all treatments (PLA, 8.1 ± 0.3
MJ; HCA, 8.4 ± 0.2 MJ; HCA +MCT, 8.4 ± 0.3 MJ).
Twenty-four-hour energy intake was similar in all treatments
for both men (PLA, 9.4 ± 0.3 MJ; HCA, 9.2 ± 0.2 MJ;
HCA+MCT, 9.3 ± 0.3 MJ) and women (PLA, 7.4 ± 0.2
MJ; HCA, 7.9 ± 0.2 MJ; HCA +MCT, 7.9 ± 0.3 MJ).
Twenty-four-hour energy intake was lower compared to
predicted 24-h energy expenditure (10.6 ± 0.3 MJ [42]) in
all treatments, confirming that the subjects were in a
negative energy balance during the test day. Energy intake
was similar for all treatments during breakfast and dinner,
but was higher with HCA compared to PLA during lunch
(PLA, 2.2 ± 0.2 MJ; HCA, 2.6 ± 0.1 MJ; P < .05; Fig. 2).
Energy intake during lunch was different between HCA and
PLA in women (PLA, 2.0 ± 0.1 MJ; HCA, 2.5 ± 0.2 MJ;
P < .01), but not in men. No relationship was found between
Factor 1 of the TFEQ (cognitive restrained/unrestrained
eating behavior) and the difference in energy intake during
lunch between the HCA and the PLA treatments (r=.05).
The ratings on the appetite-related questions throughout
the day, expressed as area under the curve (AUC) over 16 h,
corrected for the subject’s minimum score, are shown in
Table 2. The AUC of these parameters were not different
between the three treatments. Hunger scores at 20:30 h and
thirst scores after lunch were higher with HCA compared to
PLA (P < .05 and P < .01, respectively).
Compliance to the snacks was determined by asking the
subjects how many snacks were left. A mean of 98% of the
snacks was consumed, indicating a very high compliance to
the snacks.
4. Discussion
In the present study, we investigated the potential of
HCA and MCT on satiety, energy intake, and BW control.
The results did not support the hypothesis that HCA
induces satiety and reduces energy intake, in these subjects,
losing BW.
Results on the effectiveness of HCA ingestion in human
studies are controversial. Our findings are in contrast with
several studies that observed decreased appetite [22,25],
reduced 24-h energy intake [26] or increased BW and/or fat
loss [22–25] after ingestion of HCA alone or in combina-
tion with other ingredients. However, other studies also
failed to find significant effects of HCA on BW loss
[28,29] or energy expenditure [30–32].
One possible reason why HCA did not reduce appetite
and food intake in the present study is the state of
Fig. 2. Energy intake during the test day. Values are means. PLA=placebo;
HCA= ( )-hydroxycitrate; MCT=medium-chain triglycerides. Statistical
significance was determined by an analysis of variance (ANOVA) for
repeated measures. * HCA significantly different from PLA ( P< .05)
during lunch.
Table 2
Area under the curve from the following 100-mm visual analogue scale
ratings completed at 10 fixed time points over 16 h (mm.h)
PLA HCA HCA+MCT P
Hunger 436 ± 37 463 ± 30 462 ± 33 ns
Appetite 540 ± 39 504 ± 35 527 ± 32 ns
Anticipated food intake 540 ± 39 534 ± 42 558 ± 54 ns
Desire to eat 494 ± 35 497 ± 31 471 ± 30 ns
Fullness 636 ± 42 705 ± 37 668 ± 26 ns
Satiety 691 ± 30 733 ± 32 714 ± 25 ns
Thirst 575 ± 30 643 ± 38 616 ± 40 ns
Values are means ± S.E. PLA= placebo; HCA=( )-hydroxycitrate;
MCT=medium-chain triglycerides. Statistical significance was deter-
mined by an analysis of variance (ANOVA) for repeated measures.
ns = no significance.
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negative energy balance of the subjects as shown by the
mean BW loss of 0.5 kg during the 2 weeks of interven-
tion. BW loss probably resulted from a diet regimen that
prescribed to refrain from food ingestion in between the
meals with exception of the given snacks and noncaloric
beverages and to minimize alcohol consumption. Because
of this weight loss in all subjects, the possible effect of
HCA, i.e., increase of satiety, reduction of food intake and
inhibition of fat synthesis, would have had to occur in a
negative energy balance. This is unlikely, since the con-
version of citrate into acetyl-CoA by ATP-citrate-lyase
only occurs when energy intake exceeds the energy
requirements of the body. When the energy requirements
of the body are not met, carbohydrate will be used in the
citric acid cycle to produce ATP for energy rather than to
form citrate, the substrate for de novo fatty acid synthesis.
It is therefore likely that the ATP-citrate-lyase is relatively
inactive when the subjects are in a negative energy
balance. Consequently, HCA would be ineffective in
inhibiting fat synthesis [20]. The ineffectiveness of HCA
when the subjects are in a negative energy balance has
also been observed in other studies [28,29]. In addition,
Westerterp-Plantenga and Kovacs [26] found a reduced
24-h energy intake in weight stable subjects as a result of
HCA ingestion using a similar experimental design, and
Mattes and Bormann [27] found a greater food intake
reduction and BW loss using HCA during 12 weeks
compared to placebo.
Negative energy balance was much greater during the
first intervention ( 1.2 kg) compared to the second and
third intervention ( 0.2 and 0.3 kg, respectively). There-
fore, HCA and HCA combined with MCTwould have had a
greater opportunity to show effectiveness during these two
latter interventions. We also examined the results after
having removed the data from the first intervention. We
did not find any effect of HCA on energy intake or appetite-
related parameters during the test day. However, when the
subjects started with the second and third intervention, they
were already in a situation of negative energy balance
compared to baseline ( 0.7 and 0.2 kg, respectively),
as they did not completely regain the weight lost during the
first intervention.
Although 24-h energy intake was similar for all treat-
ments, energy intake during lunch was higher with HCA
compared to PLA, in the women, this in contradiction to the
original hypothesis. We do not have a direct explanation for
this, as energy intake for breakfast and with snacks was
standardized and no difference in energy intake during
dinner was found between treatments. Dietary restraint is
unlikely to have played a role in the higher energy intake
during lunch with HCA compared to PLA.
The negative result on the effectiveness of HCA could
potentially be affected by its bioavailability. Water solubility
and pH level are two major components of bioavailability
that may differ between HCA compounds available on the
market. A compound complexed with calcium and pot-
assium, like the one used in the present study, is nearly
100% soluble and creates a pH level that is favorable for
maximal gastrointestinal absorption [19]. In our laboratory,
bioavailability of HCA supplemented in humans has been
assessed by van Loon et al. [31]. It was shown that ingestion
of a single dose of HCA (4.4 g) resulted in maximal plasma
HCA concentration after 60–90 min (0.12 mmol/l 1.4%
of the administered HCA, assuming 4.5 l blood and a
hematocrit of 45%) and that HCA remained present at least
for 3 h. Therefore, we assume that in our study with
sustained administration of HCA, low concentrations of
HCA were continuously present in plasma.
Whereas MCT have been repeatedly shown to have
satiating properties and to reduce food intake in humans
[11,12,36], we found no additional effect of MCT on
satiety, food intake, or BW loss. However, these studies
used a different study protocol and/or a higher dosage
MCT. Stubbs and Harbron [12] observed that substitution
of LCT with MCT (65% fat) in high-fat, high-energy diets
for 14 days decreased energy intake. Van Wymelbeke et al.
[36] found that a breakfast supplemented with MCT (43 g)
decreased energy intake during a free-choice lunch. Rolls
et al. [11] found that a small preload of MCT (ca. 18, 36, or
54 g) incorporated into a liquid meal was more effective at
suppressing energy intake of a subsequent meal presented
30 min later, compared to LCT, already with the lowest
dosage. In the present study, a lower dosage of MCT
(12 g/day) was used. The maximal amount of oral MCT
that can be tolerated in the gastrointestinal tract is small.
Ivy et al. [45] reported that administration of 30 g MCT, in
combination with cereal, caused some minor distress in
10% of the subjects. This was a reason why we kept the
MCT dosage low, as supplementation lasted for 2 weeks.
Although the supplementation occurred for a 2-week
period, this low dosage might explain why no effect of
MCT was found on energy intake. Furthermore, in the
present study, MCT was not investigated alone. Therefore,
we cannot make statements about the efficacy of MCT
themselves. Since HCA was not effective in the present
study, it is possible that a possible additional effect of MCT
was inhibited.
The supposed effectiveness of HCA through inhibition of
de novo lipogenesis, increased hepatic fatty acid oxidation,
and promotion of glycogen stores preservation did not
appear under these circumstances. Under negative energy
balance conditions, de novo lipogenesis and preservation of
glycogen reserves are highly unlikely to appear. The only
possible remaining mechanism is an increased hepatic fatty
acid oxidation. Since we did not measure hepatic fatty acid
oxidation in the present study, we cannot draw a firm
conclusion on that aspect. It might be argued that a 2-week
intervention is too short to demonstrate significant effects of
HCA or HCA combined with MCT on appetite or BW.
However, Westerterp-Plantenga and Kovacs [26] did
observe a reduced 24-h energy intake with HCA using a
similar 2-week intervention protocol in weight stable sub-
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jects, although this effect was not reflected in BW changes.
In addition, Goris and Westerterp [46] showed that 2 weeks
are sufficient for BW effects.
In summary, we showed that HCA and HCA combined
with MCT were not effective with respect to satiety and
energy intake under a negative energy balance condition.
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